Somnath Mukherjee

Somnath Mukherjee

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Corrigendum to "SPARC, a phase-I trial of pre-operative, margin intensified, stereotactic body radiation therapy for pancreatic cancer" [Radiother. Oncol. 155 (2021) 278-284].

Corrigendum to "SPARC, a phase-I trial of pre-operative, margin intensified, stereotactic body radiation therapy for pancreatic cancer" [Radiother. Oncol. 155 (2021) 278-284].

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: May 29, 2026

Pre-operative proton versus photon-based chemoradiotherapy as an addition to best systemic therapy in the management of oesophageal cancer: protocol for the UK multi-centre randomised phase 2 PROTIEUS study.

Pre-operative proton versus photon-based chemoradiotherapy as an addition to best systemic therapy in the management of oesophageal cancer: protocol for the UK multi-centre randomised phase 2 PROTIEUS study.

Journal: BMC cancer

Published: March 09, 2026

Assessment of planning organ at risk volume margins in non-adaptive pancreatic stereotactic body radiotherapy.

Assessment of planning organ at risk volume margins in non-adaptive pancreatic stereotactic body radiotherapy.

Journal: Physics and imaging in radiation oncology

Published: October 20, 2025

The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer.

The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer.

Journal: The Lancet. Oncology

Published: September 25, 2025

Research priorities for cancers of the oesophagus and stomach: recommendations from a UK and Ireland patient and healthcare professional partnership exercise.

Research priorities for cancers of the oesophagus and stomach: recommendations from a UK and Ireland patient and healthcare professional partnership exercise.

Journal: Gut

Published: July 14, 2025

Daily adaptive MR-guided stereotactic ablative re-irradiation (re-SABR) in oligometastatic liver disease: A single-institution retrospective analysis.

Daily adaptive MR-guided stereotactic ablative re-irradiation (re-SABR) in oligometastatic liver disease: A single-institution retrospective analysis.

Journal: Clinical and translational radiation oncology

Published: May 20, 2025

Non-surgical approach to operable oesophageal cancer: is it prime time yet?

Non-surgical approach to operable oesophageal cancer: is it prime time yet?

Journal: The Lancet. Oncology

Published: January 28, 2025

Tissue-resident natural killer cells support survival in pancreatic cancer through promotion of cDC1-CD8 T activity.

Tissue-resident natural killer cells support survival in pancreatic cancer through promotion of cDC1-CD8 T activity.

Journal: eLife

Published: December 10, 2024

Induction of macrophage efferocytosis in pancreatic cancer via PI3Kγ inhibition and radiotherapy promotes tumour control.

Induction of macrophage efferocytosis in pancreatic cancer via PI3Kγ inhibition and radiotherapy promotes tumour control.

Journal: Gut

Published: July 31, 2024

Development of human pancreatic cancer avatars as a model for dynamic immune landscape profiling and personalized therapy.

Development of human pancreatic cancer avatars as a model for dynamic immune landscape profiling and personalized therapy.

Journal: Science advances

Published: July 05, 2024

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial.

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 08, 2024

A systematic review of circulating predictive and prognostic biomarkers to aid the personalised use of radiotherapy in the radical treatment of patients with oesophageal cancer.

A systematic review of circulating predictive and prognostic biomarkers to aid the personalised use of radiotherapy in the radical treatment of patients with oesophageal cancer.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: January 12, 2024

Showing 1-12 of 71

Last Updated: 09/26/2026